Zomedica (ZOM)
(Real Time Quote from BATS)
$0.13 USD
0.00 (-0.08%)
Updated Apr 26, 2024 01:13 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Zomedica Corp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 91 | 115 | 195 | 62 | 1 |
Receivables | 2 | 2 | 1 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5 | 3 | 3 | 0 | 0 |
Other Current Assets | 2 | 4 | 2 | 1 | 1 |
Total Current Assets | 100 | 124 | 200 | 63 | 2 |
Net Property & Equipment | 23 | 7 | 1 | 1 | 1 |
Investments & Advances | 10 | 41 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 117 | 106 | 77 | 0 | 1 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 0 |
Total Assets | 253 | 280 | 280 | 66 | 4 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 8 | 7 | 3 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 1 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 9 | 8 | 4 | 2 | 2 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1 | 1 | 4 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 2 | 1 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 13 | 12 | 10 | 3 | 2 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 12 | 12 |
Common Stock (Par) | 381 | 381 | 381 | 105 | 39 |
Capital Surplus | 30 | 24 | 9 | 15 | 4 |
Retained Earnings | -171 | -136 | -119 | -69 | -52 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 240 | 267 | 271 | 63 | 2 |
Total Liabilities & Shareholder's Equity | 253 | 280 | 280 | 66 | 4 |
Total Common Equity | 240 | 267 | 271 | 51 | -10 |
Shares Outstanding | 979.90 | 979.90 | 979.90 | 564.00 | 108.00 |
Book Value Per Share | 0.24 | 0.27 | 0.28 | 0.09 | -0.09 |
Fiscal Year End for Zomedica Corp falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 91 | 106 | 130 | 121 |
Receivables | NA | 2 | 2 | 2 | 2 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 5 | 4 | 4 | 3 |
Other Current Assets | NA | 2 | 3 | 4 | 5 |
Total Current Assets | NA | 100 | 115 | 140 | 130 |
Net Property & Equipment | NA | 23 | 8 | 7 | 7 |
Investments & Advances | NA | 10 | 12 | 12 | 26 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 117 | 131 | 112 | 112 |
Deposits & Other Assets | NA | 1 | 7 | 3 | 2 |
Total Assets | NA | 253 | 275 | 275 | 280 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 8 | 6 | 6 | 7 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 9 | 7 | 7 | 9 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1 | 1 | 1 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 5 | 6 | 6 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 13 | 14 | 15 | 17 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 381 | 381 | 381 | 381 |
Capital Surplus | NA | 30 | 29 | 27 | 25 |
Retained Earnings | NA | -171 | -149 | -148 | -143 |
Other Equity | NA | 0 | 0 | -1 | -1 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 240 | 261 | 259 | 263 |
Total Liabilities & Shareholder's Equity | NA | 253 | 275 | 275 | 280 |
Total Common Equity | 0 | 240 | 261 | 259 | 263 |
Shares Outstanding | 979.90 | 979.90 | 979.90 | 979.90 | 979.90 |
Book Value Per Share | 0.00 | 0.24 | 0.27 | 0.26 | 0.27 |